Patents by Inventor Fakhrieh Vojdani

Fakhrieh Vojdani has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20060288449
    Abstract: The present invention describes a method for isolating a target compound from a plant, the method comprising obtaining a plant extract, passing such plant extract through a ceramic filter to obtain a permeate, and purifying the target compound from such permeate. This method, among other things, allows ultrafiltration of crude plant extracts, such as green juice homogenates.
    Type: Application
    Filed: December 12, 2005
    Publication date: December 21, 2006
    Inventors: Stephen Garger, Barry Bratcher, Fakhrieh Vojdani
  • Publication number: 20060218667
    Abstract: The present invention relates to plant produced native aprotinin and aprotinin variants having enzyme-inhibitory, immunological and pharmacokinetic properties and their preparation. In a preferred method a recombinant RNA plant virus is used to express native aprotinin+variants thereof in Nicotiana plants.
    Type: Application
    Filed: October 12, 2005
    Publication date: September 28, 2006
    Inventors: Fakhrieh Vojdani, Kenneth Palmer, Stephen Garger, Gregory Pogue
  • Publication number: 20050210543
    Abstract: We describe here an in vitro method of increasing complementarity in a heteroduplex polynucleotide sequence. The method uses annealing of opposite strands to form a polynucleotide duplex with mismatches. The heteroduplex polynucleotide is combined with an effective amount of enzymes having strand cleavage activity, 3? to 5? exonuclease activity, and polymerase activity, and allowing sufficient time for the percentage of complementarity to be increased within the heteroduplex. Not all heteroduplex polynucleotides will necessarily have all mismatches resolved to complementarity. The resulting polynucleotide is optionally ligated. Several variant polynucleotides result. At sites where either of the opposite strands has templated recoding in the other strand, the resulting percent complementarity of the heteroduplex polynucleotide sequence is increased. The parent polynucleotides need not be cleaved into fragments prior to annealing heterologous strands. Therefore, no reassembly is required.
    Type: Application
    Filed: March 14, 2005
    Publication date: September 22, 2005
    Applicant: LARGE SCALE BIOLOGY CORPORATION
    Inventors: Hal Padgett, Andrew Vaewhongs, Fakhrieh Vojdani, Mark Smith